EVENTIDE ASSET MANAGEMENT, LLC

Position in KYMR — Kymera Therapeutics, Inc.

CIK 1442891 Boston, MA

Position in KYMR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$57,817,760

+$5,601,177 QoQ

Shares Held

504,210

-19.6% QoQ

Ownership

0.606%

of shares outstanding

% of Portfolio

0.77%

of 13F equity value

Holder Rank

#30

of 273 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

EVENTIDE ASSET MANAGEMENT, LLC holds $1,774,593,873 across 55 Biotechnology names. KYMR ranks #9 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MIRM	Mirum Pharmaceuticals, Inc.	1,248,389	$146,148,900
2	ARGX	Argenx SE	125,668	$116,591,000
3	SRRK	Scholar Rock Holding Corp	2,111,410	$116,127,550
4	PCVX	Vaxcyte, Inc.	1,380,219	$80,232,130
5	AXSM	Axsome Therapeutics, Inc.	316,820	$77,548,031
6	RPRX	Royalty Pharma plc	1,380,261	$77,391,234
7	INSM	INSMED Inc	583,665	$62,230,362
8	BLTE	Belite Bio, Inc	390,829	$60,181,803

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$57,817,760	504,210	-19.6%	Shares	Sole	2026-08-14
2026-03-31	$52,216,583	626,925	+0.1%	Shares	Sole	2026-05-15
2025-12-31	$48,742,518	626,430	-2.8%	Shares	Sole	2026-02-13
2025-09-30	$36,483,794	644,590	+14.5%	Shares	Sole	2025-11-14
2025-06-30	$24,568,883	562,990	+7.2%	Shares	Sole	2025-08-14
2025-03-31	$14,373,027	525,138	+15.2%	Shares	Sole	2025-05-15
2024-12-31	$18,333,937	455,728	-10.3%	Shares	Sole	2025-02-14
2024-09-30	$24,039,001	507,902	+9.9%	Shares	Sole	2024-11-14
2024-06-30	$13,793,655	462,099	+2236.9%	Shares	Sole	2024-08-13
2024-03-31	$794,914	19,774	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.